chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ED to Hosp-Admission  Current  10/8/2021 - present (7 days)  Non-STEMI (non-ST elevated myocardial infarction) Principal problem   Hospital Problems -   POA      * (Principal) Non-STEMI (non-ST elevated myocardial infarction) Yes  Chief Complaint Patient presents with ? Shortness of Breath  Acute hypoxic respiratory failure secondary to COVID-19 pneumonia and possible mild acute on chronic diastolic heart failure -Patient presented with shortness of breath and cough.  O2 sat was 80% on room air.  He was placed on 2 LPM of O2, now with O2 sat 98%.  Chest x-ray showed minimal hazy opacification in the bases.  He tested positive for COVID-19.  He has history of chronic diastolic heart failure.  He has history of bilateral leg edema.   Severe sepsis secondary to COVID-19 pneumonia  -Patient presented with tachypnea with blunted tachycardia being on beta-blocker, with hypoxia and COVID-19 pneumonia as source of infection. -Patient was started on Decadron in the ER.  Continue Decadron 6 mg once daily.  Patient is agreeable to start remdesivir.  Procalcitonin 0.10.  Patient received ceftriaxone and azithromycin in the ED.  Will  hold further antibiotics.   Acute on chronic diastolic heart failure - looks mildy fluid overloaded on exam.  Will give furosemide 40 mg IV x1 dose.  He takes torsemide 40 mg once daily at home.  Check TTE   NSTEMI -Initial troponin 0.15, EKG did not show any acute changes.  Continue to trend troponins.  Consult cardiology.  At this time, this could be demand ischemia from severe sepsis from COVID-19 from acute on chronic diastolic heart failure but if becomes more elevated, then he may need ischemic work-up   CAD -Continue Plavix, carvedilol, statin   History of atrial fibrillation status post ablation -He follows up with a cardiologist.  Loop recorder in place.  Continue carvedilol.  Monitor on telemetry   History of hemorrhagic stroke History of vertebral basilar insufficiency with bilateral vertebral basilar stenosis -Noted   Hypertension -Carvedilol, losartan and hydralazine   Obstructive sleep apnea -We will order CPAP during hours of sleep   Myasthenia gravis -Continue pyridostigmine   History of Present Illness     Patient is an 83 y.o. male who presented to the ED with dry cough, dyspnea, fever x2 days.  He has a past medical history of hemorrhagic stroke, diastolic heart failure, CAD, history of A. fib status post ablation, myasthenia gravis.  Patient denies any chest pain.  He states that he has good appetite.  He has chronic bilateral leg swelling but not worse than usual.  No diarrhea or abdominal pain.   At the ED, O2 sat was 86% room air.  He was placed on 2 LPM of O2.  Blood pressure was 150/90, RR 28, heart rate 88.  COVID-19 test is positive.  Patient received 2 doses of motor vaccine, last dose in March 2021.  Initial troponin 0 0.15.  EKG did not show any acute changes.  Chest x-ray showed minimal hazy opacification at the lung bases. Patient was given aspirin 325 mg in the ED.  Patient was also given ceftriaxone and azithromycin and dexamethasone.   Patient will be admitted for treatment of acute hypoxic respiratory failure secondary to COVID-19 pneumonia and treatment of a possible NSTEMI
her friend also had insomnia when she took the vaccine; This is a spontaneous report from a contactable consumer (patient's friend). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number was unknown) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter shared that her friend also had insomnia when she took the vaccine. The outcome of the event was unknown. The report was not serious.   Information about lot/batch number cannot be obtained. No further information expected.
I received my first Pfizer booster for COVID-19 and a flu vaccination on 11/24/2021. On 8/14/2022, I developed a runny nose, a minor sore throat, headache, and fatigue. I just thought that I had a head cold. On 8/15/2022, I woke up with my symptoms worsened. The most prominent symptom was a severe sore throat. I also felt too fatigued to get out of bed. I also had a cough, runny nose, and low-grade fever. I took a home antigen test and got a positive result for COVID-19. When I took the test, a bold black line showed up almost immediately. I slept as much as possible. I tried to eat, though I didn't have an appetite. My throat was also so sore that anything I swallowed aside from warm liquid hurt it. I took cough drops and numbing throat spray for my throat and ADVIL for the fever. None of the medicines helped much. The numbing spray would just work for a few minutes whenever I used it. I didn't get much sleep, because whenever I coughed, it hurt my throat and would wake me up. It got even worse on 8/16/2022. I began having wheezing, and my husband feared he would have to take me to the hospital. My throat felt like it was closing up, and I was afraid I was going to lose my ability to breathe. I could barely talk at all; if I tried to talk, I would get shortness of breath. On 8/17/2022, the symptoms of 8/16/2022 continued. I had a telehealth appointment with a medical provider offered through my insurance company. I was prescribed molnupiravir to treat the COVID-19 and dexamethasone to treat my sore throat, and I began taking them that day. About 24 hours later, my sore throat began to get a little better. All of my symptoms gradually diminished from then on. On about 8/26/2022(?), I took another home antigen test and got a negative result. I was able to return to work on 8/29/2022. At that point, my symptoms were still present, but greatly diminished. I worked for just part of the day during my first week back at work, because my fatigue kept me from being able to work an entire day. At the time of this writing, I feel that I have made a full recovery from COVID-19. However, I feel that my memory now isn't as good as it was before I had COVID-19. The wheezing was the last symptom to go, and it lingered for about 3 weeks after I tested negative.
Pt developed fever, ST and presented to office with hives and edema of hands/feet> Pharynx red. Strep neg and started on prednisone for presumed angioedema. EBV titers neg when ST persisted, inflammatory markers very high. Clinically did well and by day 3 steroids much improved.  Of interest pt did have COVID in Jan 2021 with chest pain after that was evaluated with normal troponin and  EKG/ECHO by cardiology and normal, though to be anxiety
Expired vaccine used; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 01-May-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The concomitant medications information was not reported.  Treatment information was not provided.  Company Comment: This spontaneous case reports expired product administered  in a patient of an unknown age and gender who received mRNA-1273. No  associated adverse events were reported. on 1 May -2021 patient received a dose of mRNA-1273  (028A21A expired date 28-April-2021).The benefit-risk relationship of mRNA-1273  is not affected by this report.; Sender's Comments: This spontaneous case reports expired product administered  in a patient of an unknown age and gender who received mRNA-1273. No  associated adverse events were reported. on 1 May -2021 patient received a dose of mRNA-1273  (028A21A expired date 28-April-2021).The benefit-risk relationship of mRNA-1273  is not affected by this report.
Tested positive for Covid 19 on the 10th; Tested positive for Covid 19 on the 10th; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 74-year-old male patient received BNT162b2 (BNT162B2), in 2021 as dose number unknown (booster), single (Batch/Lot number: unknown), in 2021 as dose 2, single (Batch/Lot number: unknown) and in 2021 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 10Oct2022, outcome "unknown" and all described as "Tested positive for Covid 19 on the 10th". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (10Oct2022) Positive, notes: Tested positive for Covid 19 on the 10th. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Caller was consumer reporting that he "tested positive for Covid 19 on the 10th", and he just picked up the Paxlovid, and "I took it yesterday morning at 8:30 and last night at 8:40 pm.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
3/13/21 ER HPI -> transferred to hospital 88 y.o. female who presents to the Hospital Emergency Department by private auto with her daughter.  Apparently, the patient has a 2 day history of intractable nausea and vomiting.  She states she has vomited more than 5 times over the last 2 days.  She has become more and more weak.  She states she has been having coffee-ground emesis.  No definite fever.  The patient had a similar episode to this a few months ago.  The patient does take nightly ibuprofen.  She also take iron on a daily basis because of chronic anemia.  She is not on any blood thinners.  When the patient did get to the ER she had an episode of vomiting and it did appear coffee-ground.  She is having a little bit of epigastric abdominal pain.  No history of GI bleed in the past  3/16  note from Hospital Hospital Course: 88 y.o. female with a past history significant for hypertension, renal artery stenosis, arthritis, skin cancer  presented to  hospital with nausea/vomiting and transferred to another hospital on 3/13/2021 for GI evaluation. Patient developed coffee ground emesis and had NG tube placed, yielding 1800 cc of coffee-ground emesis. She was also noted to be hypertensive. A CT done at the outside hospital revealed a large hiatal hernia with a significantly distended herniated portion of the stomach and a portion in the left upper quadrant compatible with a gastric outlet obstruction. Transferred to another hospital and GI consulted. Underwent EGD on 3/14 with results as noted below. Recommended to continue PPI, avoid NSAIDs if possible and repeat EGD in 8 weeks as outpatient. NG-tube removed and tolerated diet. No further bleeding noted. Hgb remained stable. Medically stable for discharge. Counseled on medication use and diet. Patient or daughter had no further questions or concerns on discharge.
This spontaneous report as received from a registered nurse refers to a 14 year old patient of unknown gender. Medical history and drug allergies were not reported. On 22-OCT-2013, the patient was vaccinated with RECOMBIVAX HB lot # H012250, expiration date 06-FEB-2015 (concentration, dose and indication were not reported) that was exposed to three low temperature excursions of 28F for 24 hours, 31F for 24 hours and 30F for 96 hours. No adverse effect has been observed or reported. This is one of several reports from the same source. Additional information is not expected.
Swelling, redness of the admin the morning by 11/3/22 in the morning large blisters formed at the site Mupirocin and reflex initially given in the morning then discountinued and started on prednisone that same night
Patient reported having worsened vertigo  Patient seen by paramedics and vitals were stable Patient refused medical transport and signed Medical form Patient reported vertigo improved Patient will be driven home by husband
The morning of January 8th I woke to a red splotch on my left arm at injections site. As the day progressed it became more itchy and hot to the touch. It peaked over night, but by the morning of January 9th was gone.
My arm is still sore / 10 days later; My arm is still / red / 10 days later; My arm is still / swollen / 10 days later; My arm is still / warm 10 days later; This case was reported by a consumer and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd April 2021, the patient received the 1st dose of Shingrix. In April 2021, less than 2 weeks after receiving Shingrix, the patient experienced pain in arm, erythema of extremities, swelling arm and skin warm. On an unknown date, the outcome of the pain in arm, erythema of extremities, swelling arm and skin warm were not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, erythema of extremities, swelling arm and skin warm to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but selected as adult as per the vaccine indication. The patient reported that, till the day of reporting (it's been 10 days), his or her arm was sore, red, swollen and warm . The patient was asking if that was normal.
Suspected vaccination failure; Took the modern shot and got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included COVID-19 MRNA-1273 VACCINE (MODERNA (MRNA RIBONUCLEIC ACID VACCINE)) for prophylaxis.   On an unknown date, the patient received Shingles vaccine and MODERNA (MRNA RIBONUCLEIC ACID VACCINE). On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The reporter had reported for him/herself. The age group was not reported but was captured as an adult as per the vaccine indication. The age at vaccination was not reported. The patient received the Shingles vaccine and took moderna shot and got shingles. It was unknown if the reporter considered the shingles to be related to MODERNA. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided. In Source document, suspect was reported as Modern shot which was typo error, however it was captured as Moderna vaccine.
Information has been received from a nurse practitioner concerning a 72 year old male with no known medical history who on 05-FEB-2007 was vaccinated with a .065 ml dose of Zostavax vaccine live. On 12-FEB-2007 the patient developed a rash at the injection site of 4x5 cm red, warmth and tenderness. Unspecified medical attention was sought. Subsequently, the patient recovered. There was no product quality complaint involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 4/13/2007. Initial and follow up information has been received from a nurse practitioner concerning a 72 year old retired male with no known allergies or pertinent medical history who on 06-FEB-2007 was vaccinated SC in the left deltoid with a 0.65 ml first dose of ZOSTAVAX (lot # 654604/1406F). There was no illness at the time of vaccination. On 12-FEB-2007 the patient developed a rash at the injection site of 4x5 cm red, warmth, tenderness and itching. Unspecified medical attention was sought. Subsequently, the patient recovered. There was no product quality complaint involved. Additional information is not expected.
Onset of erythematous papules on face, trunk with in hours of vaccination. No fever, but mom given Tylenol. Or exam today: hives on face, trunk at swelling of hands and warmth.
Pt recv vax on 11/16/98; on 11/17/98 pt exp achiness & tiredness, headache, runny nose, chills, cough, crackling ears, no appetite
Patient describes symptoms starting the morning after receiving the vaccine of massive headache, body aches, joint aches, feeling hot and cold, jittery, and congestion.  He states that they have been increasing in intensity since they have started.  He reports that he is unable to work because of the symptoms.
pt in good hlth underwent inocuation w/Recombivax for vax against HBV infect; in late DEC92 began to exp severe migratory arthralgias, myalgias, tenosynovitis, resulting in temporara loss of function of parts of extremities;
This spontaneous report was received from a physician via a company representative, and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. On 19-JAN-2015, the patient was vaccinated with an improperly stored dose of GARDASIL, lot # J009788 with expiration date of 17-MAR-2016, (strength, dose and route of administration were reported. No adverse effects and no product quality complaints were involved. On an unknown date, the vaccine was stored at a refrigerator and the reported temperature excursion lasted 416 hours, where the lowest recorded temperature was 26 F (-3.333333333 Celsius degrees). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator (R)". This is one of several reports received from the same source. Additional information has been requested.
Numbness outside of the face; Numbness inside of the cheeks; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-Mar-2021 and was forwarded to Moderna on 17-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness inside of the cheeks) and HYPOAESTHESIA (Numbness outside of the face) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced HYPOAESTHESIA (Numbness inside of the cheeks). On 17-Mar-2021, the patient experienced HYPOAESTHESIA (Numbness outside of the face). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 16-Mar-2021 at a dose of 50 milligram. At the time of the report, HYPOAESTHESIA (Numbness inside of the cheeks) and HYPOAESTHESIA (Numbness outside of the face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   ?
CLIENT WALKED TO CAR AND FAINTED, HITTING HIS HEAD ON THE SIDE OF THE CAR.  911 CALLED.  VITALS:  BP 118/70 HR 68, RR 16, ALERT AND ORIENTED.  COMPLAINED OF DIZZINESS AND UPSET STOMACH.  CLIENT DECLINED NEED TO BE TRANSPORTED TO HOSPITAL.  EDUCATED CLIENT AND MOTHER ON S/S IN WHICH TO REACH OUT TO PCP OR CALL 911, STATED UNDERSTANDING.
Vaccine was administered 47h 15m after vial removed from refrigeration; No adverse reaction; administered 47h 15m after vial removed from refrigeration/room temperature 37h 15m prior to dose administered; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 47h 15m after vial removed from refrigeration/room temperature 37h 15m prior to dose administered), PRODUCT STORAGE ERROR (Vaccine was administered 47h 15m after vial removed from refrigeration) and NO ADVERSE EVENT (No adverse reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 055A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 14-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 47h 15m after vial removed from refrigeration/room temperature 37h 15m prior to dose administered). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was administered 47h 15m after vial removed from refrigeration) and NO ADVERSE EVENT (No adverse reaction). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered 47h 15m after vial removed from refrigeration/room temperature 37h 15m prior to dose administered), PRODUCT STORAGE ERROR (Vaccine was administered 47h 15m after vial removed from refrigeration) and NO ADVERSE EVENT (No adverse reaction) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse reaction) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (administered 47h 15m after vial removed from refrigeration/room temperature 37h 15m prior to dose administered) and PRODUCT STORAGE ERROR (Vaccine was administered 47h 15m after vial removed from refrigeration).    Concomitant drugs were not reported.  Date the vial was initially stored in the refrigerator: 02-Aug-2022  The vial did not undergo any temperature excursions other than being brought to room temperature 37h 15m prior to dose administered. Room temperature was 68-72F during this entire 37h 15m time. fridge temp 40F.  Treatment medications were not given.   Most recent FOLLOW-UP information incorporated above includes: On 15-Aug-2022: Significant live follow-up received included narrative, batch number updated.
Stinging sensation and pain from injection site to fingertips - Tylenol every 6 hours. Headache - Tylenol every 6 hours. Feel warm/feverish - temperature is 99.6; Tylenol every 6 hours. Dizzy - rest in bed and drank Gatorade. Stayed home from school on Monday, 1/10/2022.
Headache Narrative: injection site pain, left arm pain through the night, headache, fatigue, and leg pains
very sensitive to outdoor light; really tight throat that is a little hard to breathe; really tight throat that is a little hard to breathe; super anxious; This is a spontaneous report from a contactable consumer or other non-Health Care Professional.A 29-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: Unknown), dose 1 via an unspecified route of administration, administered in Arm Right on 12Aug2021 12:00 at the age of 29-years-old as DOSE 1, SINGLE for Covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. The patient received other medications of vaccination.The patient was not diagnosed with Covid 19 and has not been tested for Covid-19 Since the vaccination.The patient medical history was not reported.The patient's concomitant medications were not reported.On 12Aug2021 14:00 the patient experienced very sensitive to outdoor light, really tight throat that is a little hard to breathe, super anxious. The patient was not received any treatment .The outcome of event was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Fever 101  Headache Chills  Lethargic  Not feeling well
Red, quarter size raised welts on arms. 3 or 4 at a time on arms an some on legs. Non itchy Go away in a few days an then reappear again in different spots. Diminished after 3 months.